Boston Scientific (BSX)

Long-Term Debt

$10.92B

Quarterly · Period ending: · USD

BSX logo

BSX Long-Term Debt

Latest reported$10.92B
BSX Quarterly Long-Term Debt ($21.40M → $10.92B)
High-resolution chart · PNG

BSX long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
10,915,000,000
10,988,000,000
12,029,000,000
11,563,000,000
11,547,000,000
10,931,000,000
9,369,000,000
9,606,000,000
9,356,000,000
9,916,000,000
8,961,000,000
8,786,000,000
8,895,000,000
8,855,000,000
9,262,000,000
8,914,000,000
9,159,000,000
9,445,000,000
9,193,000,000
9,198,000,000
9,202,000,000
9,435,000,000
9,526,000,000
9,326,000,000
9,535,000,000
9,593,000,000
8,868,000,000
9,596,000,000
7,597,000,000
7,801,000,000
4,803,000,000
4,814,000,000
4,816,000,000
4,804,000,000
3,816,000,000
4,417,000,000
4,818,000,000
5,509,000,000
5,421,000,000
5,171,000,000
5,173,000,000
5,424,000,000
5,674,000,000
5,796,000,000
5,069,000,000
3,845,000,000
2,645,000,000
4,249,000,000
4,252,000,000
4,245,000,000
4,237,000,000
4,246,000,000
3,647,000,000
4,250,000,000
2,523,000,000
4,252,000,000
4,253,000,000
4,255,000,000
2,392,000,000
4,259,000,000
4,197,000,000
4,670,000,000
4,934,000,000
5,133,000,000
5,183,000,000
5,671,000,000
4,040,000,000
5,924,000,000
5,920,000,000
6,242,000,000
6,743,000,000
6,767,000,000
7,014,000,000
7,311,000,000
7,933,000,000
7,903,000,000
8,250,000,000
8,898,000,000
8,895,000,000
8,893,000,000
8,892,000,000
1,836,000,000
1,864,000,000
2,430,000,000
1,518,000,000
1,115,000,000
1,139,000,000
1,740,000,000
1,762,000,000
611,000,000
1,172,000,000
977,000,000
974,000,000
826,000,000
847,000,000
840,000,000
835,000,000
909,000,000
973,000,000
859,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.